3 hasil untuk "Eric Fujimura"
Menampilkan 1–3 · 0,14 detik · RSS
-
Artikel Jurnal Teks lengkap
Crystal structure of the FLT3 kinase domain bound to the inhibitor Quizartinib (AC220).
More than 30% of acute myeloid leukemia (AML) patients possess activating mutations in the receptor tyrosine kinase FMS-like tyrosine kinase 3 or FLT3. A small-molecule inhibitor of FLT3 (known as quizartinib or AC220) that is currently in clinical trials appears promising for the treatment of AML…
Juga tersedia di: PLOS
-
Artikel Jurnal Teks lengkap
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
Understanding humoral responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for improving diagnostics, therapeutics, and vaccines. Deep serological profiling of 232 coronavirus disease 2019 (COVID-19) patients and 190 pre-COVID-19 era controls using VirScan revealed…